A randomised study comparing satisfaction with follow up led by a trained cancer nurse versus conventional medical follow-up after primary treatment for ovarian cancer

ISRCTN ISRCTN59149551
DOI https://doi.org/10.1186/ISRCTN59149551
Protocol serial number N0263172828
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Funders University College London Hospitals NHS Foundation Trust, NHS R&D Support Funding
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
11/10/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms A Lanceley
Scientific

Gynaecological Oncology
Gynaecological Cancer Research Centre
Institute for Women's Health
University College London, Maple House, 149 Tottenham Court Road
London
W1P 9LL
United Kingdom

Phone +44 (0)20 7380 6906
Email a.lanceley@ucl.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA randomised study comparing satisfaction with follow up led by a trained cancer nurse versus conventional medical follow-up after primary treatment for ovarian cancer
Study objectivesTo elicit and compare women's satisfaction with nurse-led follow up after treatment for ovarian cancer with routine follow up, in order to generate information, which enhances the ability of service providers to meet their needs.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCancer: Ovarian
Intervention1. Conventional medical follow up
2. Follow up care led by a trained cancer nurse
Intervention typeOther
Primary outcome measure(s)

Patient satisfaction and quality of life (QOL). QOL will be measured using the European Organisation for research and treatment of cancer (EORTC) core QOL questionnaire and supplementary ovarian cancer module

Key secondary outcome measure(s)

Not provided at time of registration

Completion date30/04/2009

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target sample size at registration100
Key inclusion criteria100 patients from Gynaecological Oncology
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/11/2005
Date of final enrolment30/04/2009

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

University College London
London
W1P 9LL
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2017 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

11/10/2017: Publication reference added.